English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52087210    ???header.onlineuser??? :  901
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"bomalaski js"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-6 of 6  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2021-06-12 Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers Chang, KY;Chiang, NJ;Wu, SY;Yen, CJ;Chen, SH;Yeh, YM;Li, CF;Feng, XX;Wu, K;Johnston, A;Bomalaski, JS;Wu, BW;Gao, JJ;Subudhi, SK;Kaseb, AO;Blando, JM;Yadav, SS;Szlosarek, PW;Chen, LT
國家衛生研究院 2021-03-30 Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia Tsai, HJ;Hsiao, HH;Hsu, YT;Liu, YC;Kao, HW;Liu, TC;Cho, SF;Feng, X;Johnston, A;Bomalaski, JS;Kuo, MC;Chen, TY
國家衛生研究院 2018-05 A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers Chang, KY;Chiang, NJ;Yen, CJ;Wu, SY;Chen, SH;Johnston, A;Bomalaski, JS;Wu, BW;Chen, LT
國家衛生研究院 2017-09 A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients Tsai, HJ;Jiang, SS;Hung, WC;Borthakur, G;Lin, SF;Pemmaraju, N;Jabbour, E;Bomalaski, JS;Chen, YP;Hsiao, HH;Wang, MC;Kuo, CY;Chang, H;Yeh, SP;Cortes, J;Chen, LT;Chen, TY
國家衛生研究院 2016-05 Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC) Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT
國家衛生研究院 2014-02 Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging Allen, MD;Luong, P;Hudson, C;Leyton, J;Delage, B;Ghazaly, E;Cutts, R;Yuan, M;Syed, N;Lo Nigro, C;Lattanzio, L;Chmielewska-Kassassir, M;Tomlinson, I;Roylance, R;Whitaker, HC;Warren, AY;Neal, D;Frezza, C;Beltran, L;Jones, LJ;Chelala, C;Wu, BW;Bomalaski, JS;Jackson, RC;Lu, YJ;Crook, T;Lemoine, NR;Mather, S;Foster, J;Sosabowski, J;Avril, N;Li, CF;Szlosarek, PW

Showing items 1-6 of 6  (1 Page(s) Totally)
1 
View [10|25|50] records per page